Porphyria cutanea tarda medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Porphyria cutanea tarda}} | |||
{{CMG}}; {{AE}} | |||
{{PleaseHelp}} | |||
==Overview== | |||
==Medical Therapy== | ==Medical Therapy== | ||
[[Chloroquine]] and [[venesection]] can be part of a management strategy.<ref>{{cite journal | author=Sarkany RP | title=The management of porphyria cutanea tarda | journal=Clin Exp Dermatol | year=2001 | pages=225-32 | volume=26 | issue=3 | id=PMID 11422163}}</ref> | [[Chloroquine]] and [[venesection]] can be part of a management strategy.<ref>{{cite journal | author=Sarkany RP | title=The management of porphyria cutanea tarda | journal=Clin Exp Dermatol | year=2001 | pages=225-32 | volume=26 | issue=3 | id=PMID 11422163}}</ref> | ||
| Line 4: | Line 12: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
[[Category:Endocrinology]] | |||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 19:31, 25 July 2016
|
Porphyria cutanea tarda Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Porphyria cutanea tarda medical therapy On the Web |
|
American Roentgen Ray Society Images of Porphyria cutanea tarda medical therapy |
|
Risk calculators and risk factors for Porphyria cutanea tarda medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Medical Therapy
Chloroquine and venesection can be part of a management strategy.[1]
References
- ↑ Sarkany RP (2001). "The management of porphyria cutanea tarda". Clin Exp Dermatol. 26 (3): 225–32. PMID 11422163.